Abstract
Recent randomized controlled trials confirmed the beneficial outcomes with coronary artery bypass grafting (CABG) compared with percutaneous coronary intervention (PCI) in patients with severe three-vessel coronary artery and left main disease. An increased long-term survival after CABG is associated with a reduction in spontaneous myocardial infarction and repeat revascularization rates. While PCI treats only flow-limiting lesions, CABG treats the whole coronary artery, preventing events in the future. Due to different clinical and anatomic factors affecting the outcomes, the heart team should formulate treatment assignment recommendations.
| Translated title of the contribution | Coronary artery bypass grafting or percutaneous coronary intervention in patients with severe three vessel disease |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 1182-1188 |
| Number of pages | 7 |
| Journal | Revista Medica de Chile |
| Volume | 149 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2021 |
Bibliographical note
Publisher Copyright:© 2021 Sociedad Medica de Santiago. All rights reserved.
Fingerprint
Dive into the research topics of 'Coronary artery bypass grafting or percutaneous coronary intervention in patients with severe three vessel disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver